1/10
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Amphetamine/Dextroamphetamine
Adderall, Mydayis
Amphetamine/Dextroamphetamine Drug Class
CNS Stimulant, C-II
Amphetamine/Dextroamphetamine Dosage Forms
Oral Tablet: 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, 30 mg
Oral Capsule, Extended Release: 5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, 25 mg, 30 mg, 37.5 mg, 50 mg
Amphetamine/Dextroamphetamine Dosing By Indication
Amphetamine/Dextroamphetamine Off Label Uses
None
Amphetamine/Dextroamphetamine MOA
Non-catecholamine sympathomimetic amines with CNS stimulant activity. This drug blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increases the release of these monoamines into the extraneuronal space.
Amphetamine/Dextroamphetamine Common Adverse Effects
Hypertension, weight loss, loss of appetite, xerostomia, headache, insomnia
Amphetamine/Dextroamphetamine Efficacy Monitoring Parameters
Resolution of signs of ADHD with improved attention span and reduced impulsivity.
Amphetamine/Dextroamphetamine Safety Monitoring Parameters
BP, heart rate, weight; chest pain, seizures, heart palpitations, changes in behavior or personality, hostility.
Amphetamine/Dextroamphetamine Key Counseling Points
Avoid late evening doses due to insomnia. Extended-release capsules may be swallowed whole with or without food. Capsule contents may be sprinkled on applesauce and consumed immediately without chewing; consume entire contents. Do not divide the dose of a single capsule.
Amphetamine/Dextroamphetamine Clinical Pearls
Amphetamines have a high potential for abuse and prolonged use may lead to dependence. Misuse may cause sudden death and serious cardiovascular adverse events. Not recommended for weight loss. Product exists as a combination of amphetamine salts including amphetamine aspartate, amphetamine sulfate, dextroamphetamine aspartate, and dextroamphetamine sulfate